Evidence map›Paper›PMID 41358303›Full record

ArticlemedRxiv : the preprint server for health sciences2025

An Integrated Data-Driven Model for Clinical Phenotyping of Tuberculosis Disease Severity.

Samantha Malatesta, Karen R Jacobson, C Robert Horsburgh, Maha Farhat, Tara Carney, Krista J Gile, Eric D Kolaczyk, Laura F White

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Samantha MalatestaDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
Karen R JacobsonSection of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts, USA.
C Robert HorsburghDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
Maha FarhatDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Tara CarneyMental Health, Alcohol, Substance Use and Tobacco Research Unit, South African Medical Research Council, Tygerberg, South Africa.
Krista J GileDepartment of Mathematics and Statistics, University of Massachusetts, Amherst, Massachusetts, USA.
Eric D KolaczykDepartment of Mathematics and Statistics, McGill University, Montreal, Quebec, Canada.
Laura F WhiteDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.

Funding

BU Clinical HIV/AIDS Research Training Program (BU-CHART)T32AI052074 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Benjamin P. Linas · 2003 to 2026
$6.7M
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamicsR01AI155765 · NIAID · HARVARD MEDICAL SCHOOL · PI FARHAT, MAHA · 2020 to 2024
$3.7M
The impact of alcohol consumption on TB treatment outcomesR01AI119037 · NIAID · BOSTON MEDICAL CENTER · PI JACOBSON, KAREN R · 2016 to 2020
$3.3M
Maximizing Investigators' Research Award (R35)R35GM141821 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WHITE, LAURA FORSBERG · 2021 to 2025
$1.8M
NIAID NIH HHS R01 AI119037NIAID NIH HHS R01 AI155765NIAID NIH HHS T32 AI052074NIGMS NIH HHS R35 GM141821
6 · The paper itself

Abstract

A common approach to describing tuberculosis (TB) disease severity is to use a binary classification such as "advanced" and "minimal or early disease," though this may not fully capture the range of clinical presentations. As individuals transition through stages of disease, we expect to observe increased bacterial burden and inflammation which corresponds to worsening disease severity and increased risk of a negative outcome. We develop a new method, tuberculosis SeveriTy Assessment Tool for Informed Stratification (TB-STATIS), to understand the various disease severity phenotypes that exist at time of clinical presentation. Our method integrates data from multiple sources (i.e. smear microscopy, chest x-ray findings, symptoms, etc.) to identify a set of disease severity classes and obtain a predicted disease class for each individual given their observed data. Our approach is motivated by the statistical framework used in event-based modeling, a type of data-driven disease progression modeling. We show in simulation TB-STATIS can correctly identify the true set of disease classes with various sample sizes, data sources to integrate, and levels of uncertainty in the observed data. We apply TB-STATIS to two data sets, data from an observational TB cohort in South Africa and data from a global phase 3 clinical trial that tested the non-inferiority of two 4-month regimens compared to the standard 6-month regimen for the treatment of TB. We observe disease classes generated from TB-STATIS correlate with culture conversion, a proxy for TB treatment response. We demonstrate our approach to classifying TB disease severity generates clinically meaningful strata.

Indexed as

data integrationdisease severitypatient stratificationtreatment outcomestuberculosis

Identifiers

PMID41358303
PMCPMC12676405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.